APA (7th ed.) Citation

LA, L., Z, B., N, B., LP, B., D, E., A, F., . . . ID, P. (2021). Efficacy and safety of once-daily single-inhaler triple therapy (FF/UMEC/VI) versus FF/VI in patients with inadequately controlled asthma (CAPTAIN): A double-blind, randomised, phase 3A trial. The Lancet. Respiratory medicine, 9(1), 69. https://doi.org/10.1016/S2213-2600(20)30389-1

Chicago Style (17th ed.) Citation

LA, Lee, et al. "Efficacy and Safety of Once-daily Single-inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI in Patients with Inadequately Controlled Asthma (CAPTAIN): A Double-blind, Randomised, Phase 3A Trial." The Lancet. Respiratory Medicine 9, no. 1 (2021): 69. https://doi.org/10.1016/S2213-2600(20)30389-1.

MLA (9th ed.) Citation

LA, Lee, et al. "Efficacy and Safety of Once-daily Single-inhaler Triple Therapy (FF/UMEC/VI) Versus FF/VI in Patients with Inadequately Controlled Asthma (CAPTAIN): A Double-blind, Randomised, Phase 3A Trial." The Lancet. Respiratory Medicine, vol. 9, no. 1, 2021, p. 69, https://doi.org/10.1016/S2213-2600(20)30389-1.